VANGUARD GROUP INC 13D and 13G filings for Pacira BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Pacira BioSciences, Inc. PCRX |
VANGUARD GROUP INC | 5,098,424 10.980% |
173,229 (+3.52%) |
Filing |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX |
VANGUARD GROUP INC | 4,925,195 10.730% |
259,240 (+5.56%) |
Filing |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
VANGUARD GROUP INC | 4,665,955 10.470% |
298,689 (+6.84%) |
Filing |
| 2021-02-10 11:40 am Purchase |
2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX |
VANGUARD GROUP INC | 4,367,266 10.050% |
22,712 (+0.52%) |
Filing |